Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations

医学 血糖性 围手术期 2型糖尿病 糖尿病 外科 肥胖 胰岛素 减肥 重症监护医学 内科学 内分泌学
作者
Oscar L. Morey‐Vargas,Ali Aminian,Karen Steckner,Keren Zhou,Sangeeta R. Kashyap,Derrick Cetin,Kevin M. Pantalone,Christopher R. Daigle,Marcio L. Griebeler,W. Scott Butsch,Robert S. Zimmerman,Matthew Kroh,Hanane Saadi,Danielle Diemer,Bartolomé Burguera,Raúl J. Rosenthal,M. Cecilia Lansang
出处
期刊:Surgery for Obesity and Related Diseases [Elsevier BV]
卷期号:18 (8): 1087-1101 被引量:3
标识
DOI:10.1016/j.soard.2022.05.008
摘要

Bariatric and metabolic surgery is an effective treatment for patients with severe obesity and obesity-related diseases. In patients with type 2 diabetes, it provides marked improvement in glycemic control and even remission of diabetes. In patients with type 1 diabetes, bariatric surgery may offer improvement in insulin sensitivity and other cardiometabolic risk factors, as well as amelioration of the mechanical complications of obesity. Because of these positive outcomes, there are increasing numbers of patients with diabetes who undergo bariatric surgical procedures each year. Prior to surgery, efforts should be made to optimize glycemic control. However, there is no need to delay or withhold bariatric surgery until a specific glycosylated hemoglobin target is reached. Instead, treatment should focus on avoidance of early postoperative hyperglycemia. In general, oral glucose-lowering medications and noninsulin injectables are not favored to control hyperglycemia in the inpatient setting. Hyperglycemia in the hospital is managed with insulin, aiming for perioperative blood glucose concentrations between 80 and 180 mg/dL. Following surgery, substantial changes of the antidiabetic medication regimens are common. Patients should have a clear understanding of the modifications made to their treatment and should be followed closely thereafter. In this review article, we describe practical recommendations for the perioperative management of diabetes in patients with type 2 or type 1 diabetes undergoing bariatric surgery. Specific recommendations are delineated based on the different treatments that are currently available for glycemic control, including oral glucose-lowering medications, noninsulin injectables, and a variety of insulin regimens.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
在水一方的应助被ldx采纳,获得10
1秒前
机智的凝琴完成签到 ,获得积分10
1秒前
牧百川发布了新的文献求助10
2秒前
NexusExplorer的应助被轻松的秋采纳,获得10
2秒前
等待的剑身完成签到,获得积分10
3秒前
搜集达人的应助被happily遇采纳,获得10
3秒前
海鸥吃薯条完成签到,获得积分10
3秒前
4秒前
Pt-SACs完成签到,获得积分10
4秒前
wickedjon完成签到,获得积分10
5秒前
华仔的应助被清风徐来采纳,获得10
5秒前
Four_twos完成签到,获得积分10
5秒前
高高发布了新的文献求助10
5秒前
6秒前
kong发布了新的文献求助10
6秒前
exile发布了新的文献求助10
6秒前
小涵完成签到,获得积分10
6秒前
Nole的应助被爱科研的小导航采纳,获得10
6秒前
彭于晏的应助被郭姗姗采纳,获得10
7秒前
8秒前
8秒前
drizzle发布了新的文献求助10
9秒前
9秒前
高高板凳完成签到,获得积分10
10秒前
大模型的应助被yjt采纳,获得10
10秒前
11秒前
高高完成签到,获得积分20
11秒前
freelancerart完成签到,获得积分10
11秒前
PennPeak发布了新的文献求助10
12秒前
溪午不闻钟完成签到,获得积分10
13秒前
初景发布了新的文献求助10
13秒前
13秒前
情怀的应助被yanhong采纳,获得30
14秒前
14秒前
小毛豆发布了新的文献求助10
15秒前
15秒前
molihuakai的应助被小半采纳,获得10
16秒前
还游完成签到,获得积分10
16秒前
念念完成签到,获得积分20
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184107
求助须知:如何正确求助?哪些是违规求助? 9573216
关于积分的说明 21829992
捐赠科研通 7781128
什么是DOI,文献DOI怎么找? 3434230
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480674